Skip to content
Unrated Drug recall · FDA · Published July 30, 2014

Pfizer Recalls Depo-Medrol Due to pH Failure

Pfizer recalls 93,800 vials of Depo-Medrol (methylprednisolone acetate) due to failed pH specifications. Check lot numbers H43272 and H43265.

🇺🇸 FDA recall #D-1537-2014DrugPfizer ›
Take action

Contact the company

Recalling firmPfizer Inc.235 East 42nd Street · New York, NY 10017-5703
✎ GovInfoNow plain-language explainer

Pfizer Inc. is recalling Depo-Medrol (methylprednisolone acetate injectable suspension USP), 40 mg/mL, in 1 mL single-dose vials because the product failed a pH specification test. The issue was identified during a stability test at the nine-month interval, where the pH measured 2.9 against a required range of 3.0 to 7.0. Approximately 93,800 vials are affected by this nationwide recall. Read more at govinfonow.com/recall/45924-pfizer-inc-recalls-depo-medrol-methylprednisolone-acetate-injectable-suspension-usp.

Source Summary by GovInfoNow · govinfonow.com/recall/45924-pfizer-inc-recalls-depo-medrol-methylprednisolone-acetate-injectable-suspension-usp · Updated October 12, 2026 · FDA enforcement record: FDA #D-1537-2014

Cite this page

“Pfizer Recalls Depo-Medrol Due to pH Failure.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/45924-pfizer-inc-recalls-depo-medrol-methylprednisolone-acetate-injectable-suspension-usp. Based on FDA recall #D-1537-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1537-2014%22&limit=1).

The FDA announced on July 30, 2014, that Pfizer Inc. is recalling Depo-Medrol injectables due to a failed pH specification. The agency classified the Class III recall as voluntary.

How to tell if you have it

  • Brand: Pfizer
  • Product: Depo-Medrol (methylprednisolone acetate injectable suspension USP), 40 mg/mL, 1 mL Single-Dose Vial
  • NDC: 0009-3073-03 and 0009-3073-23
  • Lot codes: H43272 and H43265
  • Expiration date: 09/14
  • Quantity: 93,800 vials

The hazard

A pH result of 2.9 was obtained at the 9-month stability test interval at 25C/60%RH, which falls outside the registered specification of 3.0 to 7.0.

Context

GovInfoNow's records show Pfizer Inc. has 71 other recalls on record since November 26, 2012. Recent Pfizer recalls include a sodium bicarbonate injection recall for lack of sterility assurance on August 4, 2025, and a Bicillin L-A injectable recall for particulate risk on July 10, 2025. Other recent recalls of similar products include a Cipla Diclofenac Gel recall for failed pH specifications (December 22, 2025), a Pfizer Dopamine HCl Inj recall for lack of sterility risk (September 4, 2026), and an Apotex Paxil CR 37.5mg Tablets recall for failed stability testing (August 13, 2026).

How to tell if you have this one

Look for Depo-Medrol (methylprednisolone acetate injectable suspension USP), 40 mg/mL, in 1 mL single-dose vials. Check for NDC numbers 0009-3073-03 or 0009-3073-23. Affected lots are H43272 and H43265 with an expiration date of 09/14.

  • Brand
    Pfizer
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.6 years after the firm started it.

1. Firm started the recall: Jul 30, 201412. FDA classified it Class III: Aug 12, 201423. Published in FDA’s Enforcement Report: Aug 20, 201434. FDA terminated the recall: Mar 22, 2017420142017
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1537-2014 (July 30, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1537-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA